

As screening and early treatment for type 1 diabetes become more widespread, the European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception (EDENT1FI) consortium highlights the need for clearer, more consistent terminology. In this context, the group proposes a set of preferred terms to support communication around early-stage type 1 diabetes, including the use of ‘early-stage’ or ‘presymptomatic’ type 1 diabetes for stages 1 and 2, and ‘symptomatic type 1 diabetes’ for stage 3.
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet
Diabetes & Endocrinology
|15th Jan, 2026
|The Lancet